Based on this, mutations on oncogenes KRAS, BRAF, and NRAS, and tumor suppressor genes APC, SMAD4, and TP53 require more attention in the context of (single-cell) tumor heterogeneity and need to be investigated in more detail as we have in our study. This evidence concerns the gene SMAD4 and neoplasm.